Is Early Reimplantation of the Duodenal–Jejunal Bypass Liner Viable?

The aim of this study was therefore to investigate the safety, feasibility and effectiveness of early (4-month) reimplantation of the DJBL in patients who show an early relapse in BMI and HbA1c after DJBL explantation.

Stein_Early-Reimplantation-of-EndoBarrier_Springer-Mar-2019.pdf

Morphic Medical, Inc.
320 Congress Street
3rd Floor
Boston, MA 02210

Home
RESET@
Clinical Trials
Terms of Business
Privacy Policy
Cookie Policy
Patents
Copyright

Name

Message

RESET® is approved for sale in the European Union. In the United States RESET® is limited to Investigational Use Only.
©2024 Morphic Medical, Inc. All Rights Reserved.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

We respect your privacy. Morphic Medical’s website may collect standard information such as IP address, browser type, and usage statistics to improve your experience. We do not collect sensitive personal data unless you choose to provide it (e.g. via contact forms).

By continuing to use this site, you acknowledge that:

We process your data in accordance with the:
- EU General Data Protection Regulation (GDPR)
- HIPPA (Health Insurance Portability and Accountability Act)
Any data collected is used only for site functionality, security, or user experience improvements
You have the right to access, correct, or delete your data at any time

To learn more, view our [Privacy Policy].

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies Enabled Disabled